1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Airborne precautions are needed against COVID-19
2
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Dergi:
Yazar(lar) :
Yıl :
2020
Molecular Aspects of COVID-19 Differential Pathogenesis In the absence of therapeutic interventions, and a possible vaccine candidate, the spread of
COVID-
19 disease and associated fatalities are on the rise The epidemiological data indicate that age, sex, and cardio-metabolic disease have a significant impact on the spread and severity of
COVID-
19. COVID-19
3
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 Therapeutic and Prevention
4
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 and the Eye
5
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Of chloroquine and COVID-19 COVID-19
6
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 precautions and recommendations
7
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Azithromycin for severe COVID-19
8
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Pathology and Therapeutics of COVID-19: A Review COVID-
19 pandemic has taken over the world. COVID-
19 cases were first reported in December 2019 in China; it affects the lungs causing mild to severe respiratory disease. The article will provide a good insight into the
COVID-
19 infection.
9
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Procalcitonin levels in COVID-19 patients Coronavirus disease 2019 (
COVID-
19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic This study analysed 95 SARS-CoV-2-infected patients, including 62 moderate
COVID-
19 patients, 21 severe
COVID-
19 patients and 12 critical
COVID-
19 patients We demonstrate that PCT may be an indicator of disease severity in
COVID-
19 and may contribute to determining the severity of patients infected with SARS-CoV COVID-19
10
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Extra-respiratory manifestations of COVID-19 Coronavirus disease 2019 (
COVID-
19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. clinical presentations associated with SARS-CoV-2 infection, allowing the consideration of
COVID-
19 in differential diagnoses. -
19. COVID-19
11
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Standing out from the crowd in treating COVID-19
12
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Use of antiviral drugs to reduce COVID-19 transmission
13
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Drug repurposing against COVID-19: focus on anticancer agents Abstract Background The very limited time allowed to face the
COVID-
19 pandemic poses a pressing challenge to find proper therapeutic approaches. Most drugs considered for repurposing/repositioning in the therapy of the
COVID-
19 outbreak are commercially available and their dosage and toxicity in Several drugs being re-considered for
COVID-
19 therapy are or have been used in cancer therapy.
14
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Emerging vaccine delivery systems for COVID-19
15
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Current Status of COVID-19 Therapies and Drug Repositioning Applications rapid and global spread of a new human coronavirus (SARS-CoV-2) has produced an immediate urgency to discover promising targets for the treatment of
COVID -
19. Here, we review current information concerning the global health issue of
COVID-
19 including promising approved drugs and ongoing clinical trials for prospective
16
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Amphotericin B as antiviral drug: Possible efficacy against COVID-19 COVID-
19 is regarding the new genera of coronaviridae that appear the first time in Wuhan, China, in early December 2019. Due to the continuous spreading of the novel
COVID-
19 with the exponential rise in death numbers, new therapeutic development is urgent, in general, there -
19. covid-19
17
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 and cancer care in Bermuda
18
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Combating devastating COVID-19 by drug repurposing The recent pandemic of
COVID-
19 (coronavirus disease 2019), caused by a viral infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus As no drugs are available to treat this life-threatening disease and the mortality rate due to
COVID-
19 is high, there is an utmost need to attempt to This article emphasises possible drug candidates in the treatment of
COVID-
19. Most of these drugs were found to be effective in in vitro studies. COVID-19
19
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Regulators split on antimalarials for COVID-19
20
Konferans Bildirileri

Konferans Bildirileri
Kaynak
:
Yazar(lar) :
Konu :
Communication, Networking and Broadcast Technologies, Components, Circuits, Devices and Systems, Computing and Processing, Fields, Waves and Electromagnetics, General Topics for Engineers, Power, Energy and Industry Applications, Robotics and Control Systems, Signal Processing and Analysis
Yıl :
2021
A Conceptual Deep Learning Framework for COVID-19 Drug Discovery Accordingly, a framework has been proposed to show how
COVID-
19 drug development can benefit from the potentials of AI and DL. COVID-19 COVID-19 drug discovery covid-19
21
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Springer Science and Business Media LLC
Yazar(lar) :
Yıl :
2020
Antimicrobial stewardship and COVID-19
22
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Directly Acting Antivirals for COVID-19: Where Do We Stand? -
19). This rapid review aims to describe the directly acting antivirals that have been examined for use in the management of
COVID-
19. -
19 to identify for case reports, case series, observational studies, and randomized controlled studies describing the use of antivirals in
COVID-
19. COVID-19
23
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 The
COVID-
19 pandemic is posing an unprecedented sanitary threat. The repositioning of available drugs to treat
COVID-
19 is the only and rapid option in the face of the lack of direct antiviral agents and vaccines available -
19’s worst complications. COVID-19
24
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development Understanding the pathobiology of
COVID-
19 could aid scientists in their discovery of potent antivirals by elucidating unexplored viral pathways. In this review, we focus on the recent advances of
COVID-
19 drug and vaccine development using artificial intelligence and the potential of intelligent training for the discovery of
COVID-
19 therapeutics. COVID-19
25
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Lianzhou Huang
,
Yuanqiu Chen
,
Ji Xiao
,
Weisheng Luo
,
Feng Li
,
Yuan Wang
,
Yiliang Wang
,
Yifei Wang
Yıl :
2020
Progress in the Research and Development of Anti-COVID-19 Drugs COVID-
19 spread rapidly around the world in a short time. of specific drugs for the treatment of
COVID-
19. We also discussed the strategies of the development of anti-
COVID-
19 drugs in the future. COVID-19 anti-COVID-19 drugs
26
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Informa UK Limited
Yazar(lar) :
Yıl :
2021
COVID-19 and early human milk lactoferrin
27
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Tamoxifen from chemotherapy to antiviral drug: Possible activity against COVID-19 Coronavirus disease 2019 (
COVID-
19) is regarding the new genera of coronaviredia that appeared for the first time in Wuhan, China, in early December 2019 Due to the continuous spread of the novel
COVID-
19 with the exponential rise in death numbers, new therapeutic development is urgent; in general, there Hence, this review will discuss the most recent information about the antiviral action of TAM against
COVID-
19 infection by trying to give a deep understanding covid-19
28
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Signal amplification by reversible exchange for COVID-19 antiviral drug candidates Abstract Several drug candidates have been proposed and tested as the latest clinical treatment for coronavirus pneumonia (
COVID-
19). This technique may provide new opportunities in diagnosis and research of
COVID-
19.
29
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 update: The race to therapeutic development The
COVID-
19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an unprecedented challenge to global public health At the time of this review,
COVID-
19 has been diagnosed in over 40 million cases and associated with 1.1 million deaths worldwide. We highlight two major lines of therapeutic strategies for
COVID-
19 treatment: 1) repurposing the existing drugs for use in
COVID-
19 patients, such as COVID-19